Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bioorg Med Chem ; 26(9): 2262-2270, 2018 05 15.
Artigo em Inglês | MEDLINE | ID: mdl-29472127

RESUMO

S-NeuAc-α(2-6)-di-LacNAc (5) was efficiently synthesized by a [2+2] followed by a [1+4] glycosylation, and later conjugated with 1,2-dilauroyl-sn-glycero-3-phosphoethanolamine (DLPE) to form both single-layer and multi-layer homogeneous liposomes in the presence of dipalmitoyl phosphatidylcholine (DPPC) and cholesterol. These liposomes were found to be weak inhibitors in both the influenza virus entry assay and the hemagglutination inhibition assay. The single layer liposome was found to more efficiently interfere with the entry of the H1N1 influenza virus into MDCK cells than the multilayer liposome containing 5.


Assuntos
Antivirais/farmacologia , Lipossomos/química , Oligossacarídeos/química , Zanamivir/farmacologia , Animais , Colesterol/química , Cães , Glicosilação , Glicoproteínas de Hemaglutininação de Vírus da Influenza/metabolismo , Vírus da Influenza A Subtipo H1N1/efeitos dos fármacos , Células Madin Darby de Rim Canino , Oligossacarídeos/síntese química , Fosfatidiletanolaminas/química , Internalização do Vírus/efeitos dos fármacos
2.
Oncotarget ; 8(12): 20086-20091, 2017 Mar 21.
Artigo em Inglês | MEDLINE | ID: mdl-28423615

RESUMO

Recent genome-wide association studies have established the association between EXOC3L2 rs597668 variant and Alzheimer's disease (AD) in European population. However, recent studies reported inconsistent results in Asian population. Here, we performed a systematic review and meta-analysis to evaluate the impact of rs597668 on AD risk in Asian population using a total of 8686 samples including 2855 cases and 5831 controls. Meanwhile, we selected 17,008 AD cases and 37,154 controls in European population to evaluate the potential heterogeneity between East Asian and European populations. In East Asian population, we identified no potential heterogeneity with P=0.31 and I2 = 15.8%. By meta-analysis, we identified positive association between rs597668 and AD risk with P=0.023, OR=0.93, 95% CI 0.87-0.99. We further found significant heterogeneity in pooled Asian and European populations with P<0.0001 and I2 = 87.7%. The meta-analysis indicated negative association with P=0.66, OR=0.97, 95% CI 0.85-1.11. In summary, all these findings indicate that rs597668 C allele is a risk factor for AD in European population with OR=1.18 and P=2.49E-13. However the rs597668 C allele played a protective role in AD with OR=0.93 and P=0.023 in East Asian population.


Assuntos
Doença de Alzheimer/epidemiologia , Doença de Alzheimer/genética , Predisposição Genética para Doença , Polimorfismo Genético/genética , Proteínas de Transporte Vesicular/genética , Ásia/epidemiologia , Estudos de Casos e Controles , Humanos , Prognóstico
3.
Org Biomol Chem ; 13(47): 11518-28, 2015 Dec 21.
Artigo em Inglês | MEDLINE | ID: mdl-26464117

RESUMO

An efficient, homogeneous synthesis of phospholipid conjugation of S-Neu5Acα2-6Galß1-4GluNAcß1-3 (3) and its 6-sulphate analogue 4 has been developed. The self-assembled micelles and liposomes of these trisaccharides formed in solution were found to be inhibitors interfering with the entry of the H1N1 influenza virus into MDCK cells. Compound 3 bearing a liposome and a micelle displayed superior inhibitory activity than its 6-sulfate congener 4 in both the virus neutralization assay and the hemagglutination inhibition assay.


Assuntos
Antivirais/química , Antivirais/farmacologia , Vírus da Influenza A Subtipo H1N1/efeitos dos fármacos , Oligossacarídeos/química , Oligossacarídeos/farmacologia , Internalização do Vírus/efeitos dos fármacos , Animais , Antivirais/administração & dosagem , Linhagem Celular , Cães , Humanos , Vírus da Influenza A Subtipo H1N1/fisiologia , Influenza Humana/tratamento farmacológico , Influenza Humana/virologia , Lipossomos , Micelas , Oligossacarídeos/administração & dosagem , Infecções por Orthomyxoviridae/tratamento farmacológico , Infecções por Orthomyxoviridae/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...